Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,952 | -2,695 | -10,191 | -7,396 | -4,409 |
| Depreciation Amortization | 611 | 242 | 974 | 747 | 479 |
| Accounts receivable | 164 | -149 | -136 | -66 | 31 |
| Accounts payable and accrued liabilities | -792 | 221 | -633 | -214 | -631 |
| Other Working Capital | -517 | -78 | -702 | -172 | -201 |
| Other Operating Activity | 775 | 72 | 1,116 | 474 | 550 |
| Operating Cash Flow | $-4,712 | $-2,387 | $-9,572 | $-6,628 | $-4,181 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | -221 | -54 | -57 |
| Investing Cash Flow | $-9 | $N/A | $-221 | $-54 | $-57 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 666 | 43 | 14,561 | 14,555 | 1,342 |
| Other Financing Activity | 8 | 0 | 0 | 0 | 2,444 |
| Financing Cash Flow | $674 | $43 | $14,561 | $14,555 | $3,786 |
| Exchange Rate Effect | -15 | 30 | -1 | -13 | 33 |
| Beginning Cash Position | 6,304 | 6,304 | 1,537 | 1,537 | 1,537 |
| End Cash Position | 2,242 | 3,989 | 6,304 | 9,398 | 1,119 |
| Net Cash Flow | $-4,062 | $-2,315 | $4,767 | $7,860 | $-418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,712 | -2,387 | -9,572 | -6,628 | -4,181 |
| Capital Expenditure | -9 | N/A | -221 | -54 | -57 |
| Free Cash Flow | -4,721 | -2,387 | -9,793 | -6,682 | -4,238 |